Terumo Corp. (TRUMF)
12.75
-0.32
(-2.48%)
USD |
OTCM |
Feb 27, 16:00
Terumo EPS Diluted (Quarterly) : 0.1436 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Nxera Pharma Co., Ltd. | -0.5548 |
| PeptiDream Inc. | -0.0267 |
| Stemcell Holdings, Inc. | -- |
| Healios KK | 0.1226 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 211.92M |
| Revenue (Quarterly) | 1.925B |
| Total Expenses (Quarterly) | 1.713B |
| Enterprise Value | 19.83B |
| Gross Profit Margin (Quarterly) | 51.64% |
| Profit Margin (Quarterly) | 11.01% |
| Earnings Yield | 4.57% |
| Operating Earnings Yield | 6.72% |
| Normalized Earnings Yield | 4.571 |